Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

2.79USD
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
41,826
52-wk High
$3.30
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
FY 2016 Dec '16 0.00 -0.367
Sep '16 0.00 -0.303
Jun '16 0.00 -0.392
Mar '16 0.00 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.48 32.76
P/E High - Last 5 Yrs. -- 298.85 45.44
P/E Low - Last 5 Yrs. -- 91.59 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 112.69 5.73
Price to Book (MRQ) -- 14.09 5.45
Price to Tangible Book (MRQ) -- 14.67 7.05
Price to Cash Flow (TTM) -- 72.72 23.29
% Owned Institutions 54.21 14.42 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.38 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.74 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.05 5.64
Sales - 5 Yr. Growth Rate -- 32.09 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 70.16 29.06 20.60
EPS (TTM) vs TTM 1 Yr. Ago 47.22 -- --
EPS - 5 Yr. Growth Rate -- 39.56 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.05 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 3.71 5.50 3.03
LT Debt to Equity (MRQ) -- 25.57 12.39
Total Debt to Equity (MRQ) -- 27.28 16.72
Interest Coverage (TTM) -- -101.33 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.25 54.37
Gross Margin - 5 Yr. Avg. -- 50.67 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -588.18 10.81
Operating Margin (TTM) -- -734.89 4.57
Operating Margin - 5 Yr. Avg. -- -609.81 6.23
Pre-Tax Margin (TTM) -- -708.96 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -613.30 6.67
Net Profit Margin (TTM) -- -710.36 1.73
Net Profit Margin - 5 Yr. Avg. -- -616.33 2.94
Effective Tax Rate (TTM) -- 23.27 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.59 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,066,163 860,414,701
Net Income/Employee (TTM) -- 3,124,085 101,211,889
Receivable Turnover (TTM) -- 20.78 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -142.66 0.33 11.14
Return on Assets - 5 Yr. Avg. -- 3.75 12.40
Return on Investment (TTM) -187.88 2.29 14.61
Return on Investment - 5 Yr. Avg. -- 2.93 16.14
Return on Equity (TTM) -359.90 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 4.40 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 58.24 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 33.62 29.01 99 53
13 Week 6.90 1.69 99 66
26 Week 17.42 8.50 99 79
52 Week 9.93 -6.83 99 52
YTD 197.96 161.67 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 61.60%
# of Holders: 37
Total Shares Held: 35,401,940
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.